| pubmed-article:20625763 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20625763 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20625763 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:20625763 | lifeskim:mentions | umls-concept:C0221002 | lld:lifeskim |
| pubmed-article:20625763 | lifeskim:mentions | umls-concept:C0235456 | lld:lifeskim |
| pubmed-article:20625763 | lifeskim:mentions | umls-concept:C0162680 | lld:lifeskim |
| pubmed-article:20625763 | lifeskim:mentions | umls-concept:C0034606 | lld:lifeskim |
| pubmed-article:20625763 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:20625763 | pubmed:dateCreated | 2010-9-30 | lld:pubmed |
| pubmed-article:20625763 | pubmed:abstractText | Primary hyperparathyroidism with coexisting thyroid nodular disease (TND) has been considered a contraindication for selective parathyroidectomy because the low sensitivity of preoperative localization studies, especially 99(m)Tc-sestamibi scanning (MIBI) and ultrasound. The aim of this study was to assess the impact of concomitant TND in the preoperative image studies. | lld:pubmed |
| pubmed-article:20625763 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20625763 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20625763 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20625763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20625763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20625763 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20625763 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:20625763 | pubmed:issn | 1435-2451 | lld:pubmed |
| pubmed-article:20625763 | pubmed:author | pubmed-author:Sitges-SerraA... | lld:pubmed |
| pubmed-article:20625763 | pubmed:author | pubmed-author:MunnéAssumpta... | lld:pubmed |
| pubmed-article:20625763 | pubmed:author | pubmed-author:JimenoJaimeJ | lld:pubmed |
| pubmed-article:20625763 | pubmed:author | pubmed-author:PereiraJose... | lld:pubmed |
| pubmed-article:20625763 | pubmed:author | pubmed-author:Gómez-Ramírez... | lld:pubmed |
| pubmed-article:20625763 | pubmed:author | pubmed-author:Sancho-Insens... | lld:pubmed |
| pubmed-article:20625763 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20625763 | pubmed:volume | 395 | lld:pubmed |
| pubmed-article:20625763 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20625763 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20625763 | pubmed:pagination | 929-33 | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:meshHeading | pubmed-meshheading:20625763... | lld:pubmed |
| pubmed-article:20625763 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20625763 | pubmed:articleTitle | Impact of thyroid nodular disease on 99mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism. | lld:pubmed |
| pubmed-article:20625763 | pubmed:affiliation | Endocrine Surgery Unit, Department of Surgery, Hospital Universitari del Mar, Barcelona, Spain. jgomezramirez@hotmail.com | lld:pubmed |
| pubmed-article:20625763 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20625763 | pubmed:publicationType | Comparative Study | lld:pubmed |
